Syria vs World: Hepatitis B surface antigen (HBsAg) prevalence (%)
Syria
2.9%
in 2024
World
0.6%
in 2024
Syria rank
6th
World rank
3rd
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Syria
- World
How they compare
Syria currently reports 2.9% against 0.6% in World, a difference of 2.3%.
That makes Syria's figure about 4.8 times World's.
Across all 10 years both countries report, Syria has been ahead every year.
Syria ranks 6th and World ranks 3rd of 194 countries.
Syria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Syria | World | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.5% | 0.7% | 2.7% | Syria |
| 2020s | 3.4% | 0.6% | 2.8% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Syria or World?
- Syria, at 2.9% against 0.6% in World as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Syria and World?
- 2.3%, with Syria ahead.
- How many years of comparable data are there for Syria and World?
- 10 years are reported by both, from 2015 to 2024.
- How do Syria and World rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Syria ranks 6th and World ranks 3rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.